DRDATSONS

Dr Datsons Labs Ltd

NSE: DRDATSONS

BSE: 533412

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

6.40+0.0 (+0.00%)

1 Jun, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

P/E (TTM)

P/B

P/S (TTM)

EV/EBITDA

CAPE (5Y)

ROE (TTM)

ROCE (TTM)

ROA (TTM)

Avg 3Y ROE

Earnings 3Y CAGR

Sales 3Y CAGR

Sales 5Y CAGR

Debt/Equity

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Dr Datsons Labs Ltd covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of nan% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Dr Datsons Labs Ltd covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Not enough data

Profit After Tax FY

Not enough data

ROE FY

Not enough data

EBITDA FY

Not enough data

Dr Datsons Labs Ltd Shareholding Pattern

Quarterly breakdown of Dr Datsons Labs Ltd ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	May 2011	Jun 2011	Sep 2011	Dec 2011	Mar 2012	Jun 2012	Sep 2012	Dec 2012	Mar 2013	Jun 2013	Sep 2013	Dec 2013	Mar 2014	Jun 2014	Sep 2014	Dec 2014	Mar 2015
Total Promoter	60.24	60.24	60.24	60.43	57.51	52.38	47.58	46.79	41.22	25.35	25.08	24.79	10.01	4.91	4.53	-	-
Indian Promoter	60.24	60.24	60.24	60.43	57.51	52.38	47.58	46.79	41.22	25.35	25.08	24.79	10.01	4.91	4.53	-	-
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	2.77	4.81	4.57	4.46	0.02	0.20	0.27	1.06	0.49	1.68	1.51	1.51	56.79	34.57	1.35	38.87	2.67
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00	0.98	1.35	1.68	0.47
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	2.77	4.81	4.57	4.46	0.02	0.20	0.27	0.50	0.48	1.68	1.51	1.51	56.79	33.60	0.00	37.19	2.20
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	36.99	34.95	35.19	35.12	42.47	47.41	52.15	52.15	58.29	72.97	73.41	73.69	33.20	60.52	94.12	61.13	97.33
Bodies Corporate	13.38	20.89	27.65	29.91	35.84	41.54	46.40	47.85	52.04	53.95	53.95	54.98	28.99	20.18	25.24	13.87	15.24
Others (incl. Retail) No. of shareholders	23.61 4,369	14.06 1,459	7.54 939	5.21 821	6.63 805	5.87 1,420	5.75 859	4.30 964	6.25 1,738	19.02 3,610	19.46 3,743	18.71 3,220	4.21 3,353	40.34 14,515	68.88 20,391	47.26 24,183	82.09 31,632

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Dr Datsons Labs Ltd shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

No corporate action data available.

Company Profile

Overview of Dr Datsons Labs Ltd covering business description, industry classification, key management, financial ratios, and listed exchange details.

Dr. Datsons Labs Ltd is a Indian based company. The Company engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutio...

Key personnel

Sameer Talim

Chief Executive Officer

Dr. Bhanu Pandey

President - Business Development

Mr. Lalit Shukla

President - Finance

Col ( Retd ) Ashish Kumar Basu

Head - Admin & HR

Dr. Praful Mathur, Ph.D

Head - R & D APIs

Mr. Suhas Pise

Head - Global Pharma Manufacturing & Supply Chain

Mr. Pradeep Sarode

Head Manufacturing - Formulations

Mr. Anil Kumar Singh

Head QA - Formulations

View all

Incorporated on

03 Jan 2006

Last Annual

31 Mar 2014

Last Interim

31 Mar 2012

No. of Employees

IPO date

Free Float

Website

Phone no.

Address

NO 34 AANJANEYA HOUSE POSTAL COLONY CHEMBUR, , 400071, India

Frequently Asked Questions

What is the current share price of Dr Datsons Labs Ltd?

The current share price of Dr Datsons Labs Ltd is ₹ 6.40 as of 1 Jun 2017.

What is the market capitalisation of Dr Datsons Labs Ltd?

The market capitalisation of Dr Datsons Labs Ltd stands at -.

What is the PE ratio of Dr Datsons Labs Ltd?

The Price-to-Earnings (PE) ratio of Dr Datsons Labs Ltd is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Dr Datsons Labs Ltd?

Dr Datsons Labs Ltd has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.

What is the 52-week high and low of Dr Datsons Labs Ltd?

The 52-week high of Dr Datsons Labs Ltd is - and the 52-week low is -.

What is the dividend yield of Dr Datsons Labs Ltd?

The dividend yield of Dr Datsons Labs Ltd is - based on the current market price.

What is the FII and DII holding in Dr Datsons Labs Ltd?

Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Dr Datsons Labs Ltd shares.

What sector does Dr Datsons Labs Ltd belong to?

Dr Datsons Labs Ltd operates in the Healthcare sector.

What is the beta of Dr Datsons Labs Ltd?

The beta of Dr Datsons Labs Ltd is 0.51, indicating its price volatility relative to the broader market.

What is the RSI of Dr Datsons Labs Ltd?

The 14-day Relative Strength Index (RSI) of Dr Datsons Labs Ltd is 28.85, placing it in the oversold zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Dr Datsons Labs Ltd

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Dr Datsons Labs Ltd Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile